ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00291941
Recruitment Status : Completed
First Posted : February 15, 2006
Last Update Posted : August 28, 2008
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Henogen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2007
  Actual Study Completion Date : March 2007